FIND AN EYE DOCTOR

Terms & Conditions

Tarsus Pharmaceuticals, Inc. (“Tarsus”) is providing this eye care professional search tool for informational purposes only to help patients find eye care professionals in their area who are knowledgeable about Demodex blepharitis. The selection of an eye care professional is an important decision that should be considered carefully and should not be based solely on inclusion in this search tool. This search tool is just one source of information available to you. It is your responsibility to check with your insurance company and the eye care professional if the professional is in-network for your insurance. Tarsus does not guarantee the accuracy or completeness of any information provided herein. Users should contact eye care professionals directly with all medication, insurance coverage, facility, and other site-specific inquiries. Users of this website are solely responsible for communications and interactions with any of the listed professionals, and any information users send them is not governed by Tarsus’ Terms and Conditions and Privacy Policy.

No fees have been or will be exchanged for an eye care professional’s inclusion in this locator tool. Inclusion of an eye care professional in this directory does not represent an endorsement, referral, or recommendation of Tarsus. Tarsus makes no representations or warranties about the services offered, the availability of services by any eye care professional, or the credentials, skill, or outcomes of the listed eye care professionals. The eye care professionals participating in this search tool do not necessarily endorse the use of any Tarsus product nor does the inclusion of an eye care professional in this directory imply that they will determine if XDEMVY® is right for you.

The information on this tool is updated on a quarterly basis.

Important Safety Information

Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. 

Handling the Container: Avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice: Immediately seek a physician’s advice concerning the continued use of XDEMVY if you develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions. 

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals at 1-888-421-4002 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

FIND AN EYE DOCTOR

Terms & Conditions

You are leaving the XDEMVY® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY® patient website and going to the healthcare professional website.

You are leaving the XDEMVY® patient website.

Are you a US healthcare professional?

You are leaving the XDEMVY^® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY^® patient website and going to the healthcare professional website.

You are leaving the XDEMVY^® patient website.